LT - Cholano dariniai skirti naudoti ligų, kurių atsiradimui tarpininkauja FXR ir TGR5/GPBAR1, gydymui ir (arba) profilaktikai
EN - CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF FXR AND TGR5/GPBAR1 MEDIATED DISEASES
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07J 9/00 |
(2006.01) |
|
|
A61P 13/12 |
(2006.01) |
|
|
A61K 31/575 |
(2006.01) |
|
|
A61P 1/00 |
(2006.01) |
|
|
A61P 1/04 |
(2006.01) |
|
|
A61P 1/16 |
(2006.01) |
|
|
A61P 3/00 |
(2006.01) |
|
|
A61P 3/04 |
(2006.01) |
|
|
A61P 3/06 |
(2006.01) |
|
|
A61P 3/10 |
(2006.01) |
|
|
A61P 5/38 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
A61P 37/02 |
(2006.01) |
|
|
A61P 5/50 |
(2006.01) |
|
|
A61P 9/00 |
(2006.01) |
|
|
A61P 9/10 |
(2006.01) |
|
|
A61P 43/00 |
(2006.01) |
|
|
A61K 35/00 |
(2006.01) |
|
|
A61P 17/02 |
(2006.01) |
|
|
A61P 19/02 |
(2006.01) |
|
|
C07J 31/00 |
(2006.01) |
|
|
C07J 41/00 |
(2006.01) |
|
|
A61P 21/00 |
(2006.01) |
|
|
A61P 25/00 |
(2006.01) |
|
|
A61P 29/00 |
(2006.01) |
|
|
A61P 31/00 |
(2006.01) |
|
|
A61P 31/14 |
(2006.01) |
|
|
A61P 31/18 |
(2006.01) |
|
|
A61P 31/20 |
(2006.01) |
European patent
| (11) |
Number of the document |
3626725 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
19204247.1 |
|
Date of filing the European patent application |
2015-05-28 |
| (97) |
Date of publication of the European application |
2020-03-25 |
| (45) |
Date of publication and mention of the grant of the patent |
2022-11-30
|
| (46) |
Date of publication of the claims translation |
2023-03-10
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
FI20140130 |
2014-05-29
|
IT |
Inventors
| (72) |
Angela, ZAMPELLA , IT
Stefano, FIORUCCI , IT
|
Grantee
| (73) |
Bar Pharmaceuticals S.r.l. ,
Via Gramsci, 88/A, 42124 Reggio Nell'Emilia (RE),
IT
|
Attorney or representative
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Cholano dariniai skirti naudoti ligų, kurių atsiradimui tarpininkauja FXR ir TGR5/GPBAR1, gydymui ir (arba) profilaktikai |
| |
CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF FXR AND TGR5/GPBAR1 MEDIATED DISEASES |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-05-07 |
11 |
289.00
EUR
|
Next renewal fee
|
2026-05-28 |
